Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals

Published:2016 Issue:6 Volume:91 Page:341-347
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Akuta Norio,Kobayashi Masahiro,Suzuki Fumitaka,Sezaki Hitomi,Fujiyama Shunichiro,Kawamura Yusuke,Hosaka Tetsuya,Kobayashi Mariko,Saitoh Satoshi,Suzuki Yoshiyuki,Arase Yasuji,Ikeda Kenji,Kumada Hiromitsu

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease;Hepatology Research;2024-04-25

3. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

4. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

5. Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis;World Journal of Hepatology;2021-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP